Gavras H - Search Results

1

Role of bradykinin in hypertension and the antihypertensive effect of angiotensin-converting enzyme inhibitors.

Gavras I, Gavras H. Gavras I, et al. Among authors: gavras h. Am J Med Sci. 1988 Apr;295(4):305-7. doi: 10.1097/00000441-198804000-00015. Am J Med Sci. 1988. PMID: 2834950 No abstract available.

2

Cardioprotective properties of bradykinin: role of the B(2) receptor.

Manolis AJ, Marketou ME, Gavras I, Gavras H. Manolis AJ, et al. Among authors: gavras h. Hypertens Res. 2010 Aug;33(8):772-7. doi: 10.1038/hr.2010.82. Epub 2010 May 27. Hypertens Res. 2010. PMID: 20505673 Review.

3

Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats.

Wang YX, Gavras I, Wierzba T, Gavras H. Wang YX, et al. Among authors: gavras i, gavras h. J Lab Clin Med. 1992 Mar;119(3):267-72. J Lab Clin Med. 1992. PMID: 1541876

4

A novel bradykinin antagonist with improved properties.

Lammek B, Wang YX, Gavras I, Gavras H. Lammek B, et al. Among authors: gavras i, gavras h. J Pharm Pharmacol. 1991 Dec;43(12):887-8. doi: 10.1111/j.2042-7158.1991.tb03205.x. J Pharm Pharmacol. 1991. PMID: 1687595

5

Cardioprotective potential of angiotensin-converting enzyme inhibitors.

Gavras I, Gavras H. Gavras I, et al. Among authors: gavras h. Clin Cardiol. 1991 Aug;14(8 Suppl 4):IV68-71; discussion IV83-90. Clin Cardiol. 1991. PMID: 1893645 Free article. Review.

6

A new highly potent antagonist of bradykinin.

Lammek B, Wang YX, Gavras I, Gavras H. Lammek B, et al. Among authors: gavras i, gavras h. Peptides. 1990 Sep-Oct;11(5):1041-3. doi: 10.1016/0196-9781(90)90031-y. Peptides. 1990. PMID: 2284196

7

Angiotensin-converting enzyme inhibitors in hypertension and congestive heart failure.

Gavras I, Gavras H. Gavras I, et al. Among authors: gavras h. Adv Intern Med. 1990;35:249-67. Adv Intern Med. 1990. PMID: 2405595 Review. No abstract available.

8

Bradykinin antagonism and prostaglandins in blood pressure regulation.

Mulinari R, Gavras I, Franco R, Gavras H. Mulinari R, et al. Among authors: gavras i, gavras h. Hypertension. 1989 Jun;13(6 Pt 2):960-3. doi: 10.1161/01.hyp.13.6.960. Hypertension. 1989. PMID: 2567708

9

Hypertension in the aging patient. Implications for the selection of drug therapy.

Bursztyn M, Gavras I, Gavras H. Bursztyn M, et al. Among authors: gavras i, gavras h. J Am Geriatr Soc. 1989 Aug;37(8):814-8. doi: 10.1111/j.1532-5415.1989.tb02246.x. J Am Geriatr Soc. 1989. PMID: 2754162

10

The antihypertensive contribution of bradykinin as assessed by a specific bradykinin antagonist.

Benetos A, Gavras H, Stewart JM, Vavrek R, Hatinoglou S, Gavras I. Benetos A, et al. Among authors: gavras i, gavras h. Agents Actions Suppl. 1987;22:355-64. Agents Actions Suppl. 1987. PMID: 2829598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

374 results

Search Page

Filters